Arcus Biosciences Inc. (RCUS)
NYSE · Healthcare
Arcus Biosciences Inc. Cash on Hand 2017–2025
Arcus Biosciences Inc. annual cash on hand history from 2017 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Arcus Biosciences Inc. cash on hand as of December 31, 2025: 222.0M, a 48.00% increase year-over-year.
- Arcus Biosciences Inc. cash on hand for 2025 were 222.0M, a 48.00% increase from 2024.
- Arcus Biosciences Inc. cash on hand for 2024 were 150.0M, a 18.11% increase from 2023.
- Arcus Biosciences Inc. cash on hand for 2023 were 127.0M, a 38.35% decrease from 2022.
- Arcus Biosciences Inc. cash on hand for 2022 were 206.0M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Arcus Biosciences Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $222 |
| 2024 | $150 |
| 2023 | $127 |
| 2022 | $206 |
| 2021 | $148 |
| 2020 | $173 |
| 2019 | $58 |
| 2018 | $71 |
| 2017 | $98 |
Arcus Biosciences Inc. Cash on Hand — FAQ
Arcus Biosciences Inc. (RCUS) cash on hand over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RCUS's cash on hand history?
The chart and table above show Arcus Biosciences Inc.'s cash on hand by year and by quarter, including the growth rate.